Doubts About Job Market Turning Round Quickly Simple To Perceive
Biopharma professionals don’t have a lot hope for the biopharma job market turning round this yr, primarily based on a...
Pharmaceutical Updates
Bavarian Nordic shares rise 7% following robust Q1 for vaccine gross sales
Bavarian Nordic has not too long ago secured had key vaccine approvals for chikungunya virus and mpox/smallpox. Picture credit score:...
Extra Medicare plans cowl Humira biosimilars, however use is not inspired
Medicare drug plans considerably boosted protection of biosimilar variations of the Humira rheumatoid arthritis medication this yr, however practically all...
C4 Therapeutics Cabinets BRAF Blocker, Goes All-In on A number of Myeloma Drug
C4 Therapeutics will not pour cash into its investigational BRAF inhibitor CFT1946, within the title of “strategic capital allocation,” the...
Sarepta shares fall amid FDA’s CBER appointment and weak Elevidys gross sales
Sarepta additionally reported lower-than-expected gross sales for its DMD gene remedy Elevidys. Credit score: SOPA Photos through Getty Photos. Sarepta...
Few drugmakers use a more moderen take a look at for contamination, risking horseshoe crabs
Many giant drugmakers are nonetheless utilizing a decades-old take a look at — derived from horseshoe crabs — as a...
PTC Nosedives Regardless of Claiming Part II Win for Huntington’s Hopeful
PTC Therapeutics introduced new knowledge Monday from a Part II trial exhibiting that Huntington’s hopeful PTC518 might modify a key...
FDA accepts Novo Nordisk’s NDA for weight administration remedy
On approval, the remedy would mark the primary oral glucagon-like peptide-1 treatment for persistent weight administration. Credit score: Valente Romero/Shutterstock....
STAT+: Up and down the ladder: The most recent comings and goings
Employed somebody new and thrilling? Promoted a rising star? Lastly solved that hard-to-fill spot? Share the information with us, and...
Pliant Axes 45% of Workforce To Save Money, Help Late-Stage Medical Trials
About two months after discontinuing the Section IIb/III BEACON-IPF examine of idiopathic pulmonary fibrosis drug candidate bexotegrast, Pliant Therapeutics introduced...
Q1 earnings pulse examine: corporations tentative on pharma-specific tariffs
The Q1 earnings season has supplied a window into what the pharmaceutical business expects from US President Donald Trump’s tariffs...
Millipore Sigma so as to add tariff surcharges on merchandise shipped to the U.S.
Millipore Sigma, one of many largest suppliers of medical analysis merchandise, will begin including a short lived tariff surcharge to...
Lilly Unfazed as CVS Picks Novo’s Aspect in Weight problems Market Battle
Eli Lilly has pulled forward of rival Novo Nordisk within the weight problems market, in response to analysts, simply as...
Traders insist halted biotech IPOs will return in 2025
Panellists Dirk Kersten, Max Klement, Alastair Kilgour, and John Rudy at LSX World Congress 2025 projected an eventual return of...
Sen. Collins slams NIH analysis cuts, urges funding be restored
WASHINGTON — Sen. Susan Collins (Maine), the Republican chair of the Senate Appropriations Committee, rebuked the Trump administration for reducing...
